Meige's syndrome during long-term dopaminergic therapy in Parkinson's disease.
D000368:Aged; D001764:Blepharospasm / Q000139:chemically induced; D002230:Carbidopa / Q000009:adverse effects*; D004421:Dystonia / Q000139:chemically induced*; D005152:Facial Muscles; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D008336:Mandibular Diseases / Q000139:chemically induced; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D013577:Syndrome; D013997:Time Factors
D007980:Levodopa; D002230:Carbidopa